SCHEMBL23510085

SCHEMBL23510085

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc(-n5c6ccccc6c6ccccc65)c(-c5ccc6c7ccccc7n(-c7ccc8c(c7)c7ccccc7n8-c7ccccc7)c6c5)c4)cc3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
RAC2 P15153 1/20 0.34
RAC3 P60763 1/20 0.34
CDC42 P60953 1/20 0.34
RAC1 P63000 1/20 0.34
PTGER4 P35408 1/20 0.34
AVPR1A P37288 1/20 0.33
HDAC4 P56524 1/20 0.33
KMT2A Q03164 3/20 0.31
MEN1 O00255 2/20 0.31
HSP90AA1 P07900 1/20 0.31
MAPT P10636 1/20 0.31
NR3C1 P04150 1/20 0.31
TSPO P30536 1/20 0.31
ESR1 P03372 1/20 0.30
ESR2 Q92731 1/20 0.30
IL1R1 P14778 1/20 0.30
RXRA P19793 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23510146 1.00 KDM4E (0.39) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL23510095 0.97 KDM4E (0.38) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL23510204 0.97 L3MBTL1 (0.40) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL23510359 0.96 KDM4E (0.38) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL23510367 0.96 L3MBTL1 (0.39) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL23510083 0.96 L3MBTL1 (0.39) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL23510197 0.96 L3MBTL1 (0.41) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL23510143 0.96 L3MBTL1 (0.41) KDM4EATML3MBTL1PTGER4AVPR1A
SCHEMBL23510354 0.95 KDM4E (0.38) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL23510373 0.94 L3MBTL1 (0.40) KDM4EATML3MBTL1RAC2RAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3862351-A1 COMPOUND, COMPOSITION INCLUDING THE SAME, LIQUID COMPOSITION, AND ORGANIC ELECTROLUMINESCENT DEVICE Samsung Electronics Co., Ltd. (KR) 2021-08-11 EP disclosed
US-20210184132-A1 COMPOUND, COMPOSITION INCLUDING THE SAME, LIQUID COMPOSITION, AND ORGANIC ELECTROLUMINESCENT DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210184132-A1 COMPOUND, COMPOSITION INCLUDING THE SAME, LIQUID COMPOSITION, AND ORGANIC ELECTROLUMINESCENT DEVICE TERT, TELO2, POT1 KDM4E 1003/4885ATM 1487/4885L3MBTL1 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.